Role of 5-HT2C receptors in dyskinesia; International Journal of Pharmacy and Pharmaceutical Sciences; Vol. 8, iss. 1
| Parent link: | International Journal of Pharmacy and Pharmaceutical Sciences Vol. 8, iss. 1.— 2016.— [P. 5-10] |
|---|---|
| Main Author: | |
| Corporate Author: | |
| Other Authors: | |
| Summary: | Title screen By integrating knowledge gained by pharmacogenetic, neuroanatomical and pharmacological studies, a model can be constructed how serotonin (5-HT) affects the vulnerability to induce tardive dyskinesia. From neuroanatomical studies, it can be concluded that 5-HT inhibits the release ofdopamine (DA) within the dorsal striatum by affecting 5-HT2C receptors and also within the ventral striatum and prefrontal cortex by affecting 5-HT2A receptors. However, considering the low affinity of DA for its receptors, it is unlikely that the so released DA is able to displace atypicalantipsychotics from DA D2 and D3 receptors. 5-HT2C receptors and, to a lesser extent, 5-HT2A receptors, have constitutive activity and therefore,atypical antipsychotics can have inverse agonistic effects. It is hypothesized that decreasing the activity of 5-HT2 receptor carrying medium spinyneurons (MSNs) within the dorsal striatum represents the mechanism showing how atypical antipsychotics have limited ability to cause tardivedyskinesia. |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://innovareacademics.in/journals/index.php/ijpps/article/view/8736 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=649685 |
MARC
| LEADER | 00000naa0a2200000 4500 | ||
|---|---|---|---|
| 001 | 649685 | ||
| 005 | 20250306145737.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\14847 | ||
| 090 | |a 649685 | ||
| 100 | |a 20160801d2016 k||y0rusy50 ba | ||
| 101 | 0 | |a eng | |
| 102 | |a IN | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Role of 5-HT2C receptors in dyskinesia |f A. J. M. Loonen, S. A. Ivanova | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 320 | |a [References: 62 tit.] | ||
| 330 | |a By integrating knowledge gained by pharmacogenetic, neuroanatomical and pharmacological studies, a model can be constructed how serotonin (5-HT) affects the vulnerability to induce tardive dyskinesia. From neuroanatomical studies, it can be concluded that 5-HT inhibits the release ofdopamine (DA) within the dorsal striatum by affecting 5-HT2C receptors and also within the ventral striatum and prefrontal cortex by affecting 5-HT2A receptors. However, considering the low affinity of DA for its receptors, it is unlikely that the so released DA is able to displace atypicalantipsychotics from DA D2 and D3 receptors. 5-HT2C receptors and, to a lesser extent, 5-HT2A receptors, have constitutive activity and therefore,atypical antipsychotics can have inverse agonistic effects. It is hypothesized that decreasing the activity of 5-HT2 receptor carrying medium spinyneurons (MSNs) within the dorsal striatum represents the mechanism showing how atypical antipsychotics have limited ability to cause tardivedyskinesia. | ||
| 461 | |t International Journal of Pharmacy and Pharmaceutical Sciences | ||
| 463 | |t Vol. 8, iss. 1 |v [P. 5-10] |d 2016 | ||
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a электронный ресурс | |
| 700 | 1 | |a Loonen |b A. J. M. |g Anton | |
| 701 | 1 | |a Ivanova |b S. A. |c specialist in the field of ecology and life safety |c Professor of Tomsk Polytechnic University, doctor of medical sciences |f 1964- |g Svetlana Aleksandrovna |3 (RuTPU)RU\TPU\pers\33859 |9 17448 | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет |b Институт неразрушающего контроля |b Кафедра экологии и безопасности жизнедеятельности |3 (RuTPU)RU\TPU\col\18720 |9 27170 |
| 801 | 2 | |a RU |b 63413507 |c 20160801 |g RCR | |
| 856 | 4 | |u http://innovareacademics.in/journals/index.php/ijpps/article/view/8736 | |
| 942 | |c CF | ||